Late-onset sepsis in very preterm infants in Norway in 2009-2018: a population-based study.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 05 10 2022
accepted: 13 01 2023
medline: 21 8 2023
pubmed: 3 2 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

To evaluate epidemiology and outcomes among very preterm infants (<32 weeks' gestation) with culture-positive and culture-negative late-onset sepsis (LOS). Cohort study using a nationwide, population-based registry. 21 neonatal units in Norway. All very preterm infants born 1 January 2009-31 December 2018 and admitted to a neonatal unit. Incidences, pathogen distribution, LOS-attributable mortality and associated morbidity at discharge. Among 5296 very preterm infants, we identified 582 culture-positive LOS episodes in 493 infants (incidence 9.3%) and 282 culture-negative LOS episodes in 282 infants (incidence 5.3%). Extremely preterm infants (<28 weeks' gestation) had highest incidences of culture-positive (21.6%) and culture-negative (11.1%) LOS. The major causative pathogens were coagulase-negative staphylococci (49%), LOS contributes to a significant burden of disease in very preterm infants and is associated with increased odds of severe BPD, cPVL and severe ROP.

Identifiants

pubmed: 36732047
pii: archdischild-2022-324977
doi: 10.1136/archdischild-2022-324977
pmc: PMC10447404
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

478-484

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Arch Dis Child Fetal Neonatal Ed. 2003 Mar;88(2):F89-93
pubmed: 12598493
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Arch Dis Child Fetal Neonatal Ed. 2021 Sep;106(5):467-473
pubmed: 33478957
Pediatr Infect Dis J. 2017 Aug;36(8):774-779
pubmed: 28709162
Can J Physiol Pharmacol. 2019 Mar;97(3):213-221
pubmed: 30273497
Pediatrics. 2017 Mar;139(3):
pubmed: 28228499
BMC Pediatr. 2017 Apr 4;17(1):98
pubmed: 28376891
Pediatr Infect Dis J. 2014 Feb;33(2):143-6
pubmed: 24418836
Lancet Child Adolesc Health. 2017 Oct;1(2):124-133
pubmed: 30169202
Pediatr Infect Dis J. 2016 Apr;35(4):401-6
pubmed: 26629870
Semin Immunopathol. 2020 Aug;42(4):451-468
pubmed: 32661735
Behav Brain Res. 1992 Jul 31;49(1):1-6
pubmed: 1388792
Early Hum Dev. 2012 May;88 Suppl 2:S69-74
pubmed: 22633519
J Pediatr. 2018 Oct;201:106-114.e4
pubmed: 30054165
Pediatrics. 2005 Mar;115(3):e269-76
pubmed: 15687416
Acta Paediatr. 2021 Jan;110(1):166-167
pubmed: 32564388
Acta Obstet Gynecol Scand. 2009;88(1):110-5
pubmed: 18951221
Neonatology. 2019;116(1):42-51
pubmed: 30947195
J Pediatr. 2015 May;166(5):1193-9
pubmed: 25919728
Early Hum Dev. 2012 Jan;88(1):27-31
pubmed: 21752559
Pediatr Infect Dis J. 2014 Jan;33(1):e7-e13
pubmed: 23899966
Pediatr Infect Dis J. 2014 Mar;33(3):238-43
pubmed: 24030351
Front Pediatr. 2018 Oct 09;6:285
pubmed: 30356671
Pediatrics. 2002 Aug;110(2 Pt 1):285-91
pubmed: 12165580
Pediatr Infect Dis J. 2021 Mar 1;40(3):255-259
pubmed: 33538544
PLoS One. 2019 Nov 22;14(11):e0225407
pubmed: 31756213
Arch Dis Child Fetal Neonatal Ed. 2018 Nov;103(6):F547-F553
pubmed: 29208666
Acta Obstet Gynecol Scand. 2000 Jun;79(6):440-9
pubmed: 10857867
N Engl J Med. 2015 Jan 22;372(4):331-40
pubmed: 25607427
Pediatr Infect Dis J. 2021 May 1;40(5):403-410
pubmed: 33298760
PLoS One. 2012;7(6):e38304
pubmed: 22768043
N Engl J Med. 2019 Oct 10;381(15):1434-1443
pubmed: 31597020
Cochrane Database Syst Rev. 2015 Oct 24;(10):CD003850
pubmed: 26497056
Am J Perinatol. 2015 Jun;32(7):675-82
pubmed: 25486288
Lancet. 2003 May 24;361(9371):1789-91
pubmed: 12781540
Sci Rep. 2022 Jul 8;12(1):11675
pubmed: 35803970
Pediatr Infect Dis J. 2016 Jan;35(1):1-6
pubmed: 26368059
Pediatr Infect Dis J. 2020 Mar;39(3):232-238
pubmed: 32032307
Pediatr Infect Dis J. 2017 Sep;36(9):883-888
pubmed: 28178107
J Pediatr. 2017 Feb;181:289-293.e1
pubmed: 27908652

Auteurs

Zuzana Huncikova (Z)

Paediatric Department, Stavanger University Hospital, Stavanger, Norway.
Department of Clinical Science, University of Bergen, Bergen, Hordaland, Norway.

Anlaug Vatne (A)

Paediatric Department, Stavanger University Hospital, Stavanger, Norway.

Hans Jorgen Stensvold (HJ)

Neonatal Department, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Faculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Astri Maria Lang (AM)

Paediatric Department, Akershus University Hospital, Lorenskog, Norway.

Ragnhild Støen (R)

Department of Paediatrics, St. Olav University Hospital, Trondheim, Norway.

Anne Karin Brigtsen (AK)

Department of Neonatal Intensive Care, Oslo University Hospital Ullevaal, Oslo, Norway.

Bodil Salvesen (B)

Department of Paediatrics and Adolescents Medicine, Haukeland University Hospital, Bergen, Norway.

Knut Asbjørn Alexander Øymar (KAA)

Paediatric Department, Stavanger University Hospital, Stavanger, Norway.
Department of Clinical Science, University of Bergen, Bergen, Hordaland, Norway.

Arild Rønnestad (A)

Neonatal Department, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Faculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.

Claus Klingenberg (C)

Department of Paediatrics, University Hospital of North Norway, Tromso, Norway claus.klingenberg@unn.no.
Faculty of Health Sciences, University of Tromsø, Tromsø, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH